MRNA Covered Call: Strike Selection, Premium & Risk

Is MRNA a good covered call candidate?

MRNA (Moderna Inc.) is a mid-cap healthcare name with a low share price and excellent options liquidity. Implied volatility on this ticker is elevated, so option premiums are rich — but the same volatility cuts both ways and can move the stock hard in either direction. It pays no dividend, so every dollar of income must come from the options you sell.

Strike selection for a MRNA covered call

For MRNA covered calls, target strikes 12-18% out of the money at deltas around 0.10-0.20. Use 14-28 DTE so you can react to sharp IV crushes and moves. On a very high-volatility name like MRNA, going closer to the money chases premium at the cost of a much higher assignment probability — the risk of being called away becomes meaningful below 12-18% OTM.

Expected premium and income on MRNA

Typical monthly premium collected on MRNA runs around 3.5-6.0% of capital, which annualizes to roughly 42-72% if you sell new contracts every cycle. Capital required to run a single contract wheel on MRNA is under $5,000 — the share price and the 100-share lot size set the minimum, not the strategy.

Risk management for MRNA covered call trades

The core risk on a covered call is opportunity cost: if the stock rips through your strike, your upside is capped. You still profit, just less than someone who held the shares outright. On a very high-volatility name like MRNA, expect 5-10%+ single-day moves during stress. Size positions so one adverse gap doesn't blow up the account. Healthcare is exposed to FDA decisions, clinical trial readouts, and policy headlines that can gap the stock overnight. Pharma names need special care around PDUFA dates.

MRNA Covered Call FAQ

Related MRNA strategies